Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response
- 8 June 2006
- journal article
- Published by Springer Science and Business Media LLC in Pediatric Nephrology
- Vol. 21 (9), 1274-1280
- https://doi.org/10.1007/s00467-006-0187-2
Abstract
The aim of this study was to examine the expression of P-glycoprotein (P-gp) in CD3 lymphocytes of children with nephrotic syndrome (NS) in relation to their clinical response to glucocorticoid (GC) treatment. The examinations were performed on two groups. The study group (I) consisted of 88 children aged 2.0–20.0 years with NS, divided according to their clinical response to GC: NFR—non-frequent relapse NS; FR—frequent relapse NS; SD—steroid-dependent NS. The control group (II) consisted of 18 healthy children never treated with GC. We measured P-gp expression on CD3 lymphocytes of patients with NS using a flow cytometry assay. The CD3/P-gp was significantly higher than in controls. The difference was higher in SD (P=0.0001) and FR - (P=0.0002) group. The difference in NFR was smaller. Mean CD3/P-gp (in percent) was twice as high in SD children than in NFR, and the difference, as between FR and NFR, was statistically significant (P<0.01). Worse response to GC or dependency may be due to overexpression of P-gp. Further examinations are necessary to establish whether increased P-gp activity is a result of MDR-1 polymorphism and to determine GC response, or to ascertain if such activity is only a result of GC therapy.Keywords
This publication has 29 references indexed in Scilit:
- Multidrug resistance-1 (MDR-1) in autoimmune disorders III: Increased P-glycoprotein activity inlymphocytes from immune thrombocytopenic purpura patientsExperimental Hematology, 2003
- The editors' choiceJournal of Allergy and Clinical Immunology, 2003
- Update on glucocorticoid action and resistanceJournal of Allergy and Clinical Immunology, 2003
- EXPRESSION OF THE MULTDORUG RESISTANCE GLYCOPROTEIN 170 IN THE PERIPHERAL BLOOD LYMPHOCYTES OF RHEUMATOID ARTHRITIS PATIENTS. THE PERCENTAGE OF LYMPHOCYTES EXPRESSING GLYCOPROTEIN 170 IS INCREASED IN PATIENTS TREATED WITH PREDNISOLONERheumatology, 1996
- Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in childrenEuropean Journal of Pediatrics, 1993
- Glucocorticoid therapy for asthma: Clinical pharmacologyJournal of Allergy and Clinical Immunology, 1991
- Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft fur Padiatrische Nephrologie.Archives of Disease in Childhood, 1987
- Early identification of frequent relapsers among children with minimal change nephrotic syndrome: A report of the International Study of Kidney Disease in ChildrenThe Journal of Pediatrics, 1982
- The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone: A report of the international study of kidney disease in childrenThe Journal of Pediatrics, 1981
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1976